Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
All Brilliance Investments Limited is a private investment holding company based in the British Virgin Islands. It is primarily recognized as a significant shareholder and investment vehicle for Dr. Ge Li, the founder and chairman of the WuXi AppTec group. The company holds substantial equity stakes in major global life science entities, most notably WuXi Biologics and WuXi AppTec. While All Brilliance Investments does not directly conduct laboratory research or drug development, it is a critical part of the ownership and financing structure for one of the world's leading CRDMO platforms. Through its strategic holdings, the company is indirectly involved in the development of a wide range of therapeutic modalities and serves as a key entity for corporate governance within the broader WuXi ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on All Brilliance Investments.